- Tissue engineering in plastic and reconstructive surgery: fostering advances in the 21st century via an understanding of the present state of the art and future possibilities
-
Anand M, Bhagania M, Kaur K
- KMID: 2541849
- Arch Aesthetic Plast Surg.
- 2023 Apr;29(2):64-75.
- doi: 10.14730/aaps.2022.00710
Tissue engineering is a subfield of regenerative medicine that has been hailed as the most cutting-edge medical and surgical achievement to date. Tissue engineering aims to restore or construct whole... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidental benefits after fecal microbiota transplant for ulcerative colitis
-
Mahajan R, Midha V, Singh A, Mehta V, Gupta Y, Kaur K, Sudhakar R, Singh Pannu A, Singh D, Sood A
- KMID: 2504589
- Intest Res.
- 2020 Jul;18(3):337-340.
- doi: 10.5217/ir.2019.00108
Gut dysbiosis can result in several diseases, including infections (Clostridium difficile infection and infectious gastroenteritis), autoimmune diseases (inflammatory bowel disease, diabetes, and allergic disorders), behavioral disorders and other conditions like... -
- CITED
-
- Close
- SHARE
-
- Close
- Anatomical considerations of percutaneous transvenous mitral annuloplasty: a novel procedure for treatment of functional mitral regurgitation
-
Mehra L, Raheja S, Agarwal S, Rani Y, Kaur K, Tuli A
- KMID: 2308933
- Anat Cell Biol.
- 2016 Mar;49(1):68-72.
- doi: 10.5115/acb.2016.49.1.68
Percutaneous transvenous mitral annuloplasty (PTMA) has evolved as a latest procedure for the treatment of functional mitral regurgitation. It reduces mitral valve annulus (MVA) size and increases valve leaflet coaptation... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends of inflammatory bowel disease at a tertiary care center in northern India
-
Sood A, Kaur K, Singh A, Midha V, Mahajan R, Bansal N, Mehta V, Singh D
- KMID: 2518684
- Intest Res.
- 2021 Jul;19(3):282-290.
- doi: 10.5217/ir.2020.00010
Background/Aims: Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), is increasingly being reported from India and other Asian countries. This study looks into the changing trends... -
- CITED
-
- Close
- SHARE
-
- Close
- A simple phenotypic classification for celiac disease
-
Sood A, Midha V, Makharia G, Thelma BK, Halli SS, Mehta V, Mahajan R, Narang V, Sood K, Kaur K
- KMID: 2417681
- Intest Res.
- 2018 Apr;16(2):288-292.
- doi: 10.5217/ir.2018.16.2.288
BACKGROUND/AIMS: Celiac disease is a global health problem. The presentation of celiac disease has unfolded over years and it is now known that it can manifest at different ages, has... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of the adalimumab biosimilar Exemptia as induction therapy in moderate-to-severe ulcerative colitis
-
Midha V, Mahajan R, Mehta V, Narang V, Singh A, Kaur K, Sood A
- KMID: 2402651
- Intest Res.
- 2018 Jan;16(1):83-89.
- doi: 10.5217/ir.2018.16.1.83
BACKGROUND/AIMS: Data on the efficacy and safety of the adalimumab biosimilar Exemptia are limited. METHODS: Patients with moderate-to-severe active steroid-refractory ulcerative colitis (UC) treated at Dayanand Medical College and Hospital, India... -
- CITED
-
- Close
- SHARE
-
- Close
- Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
-
Sood A, Ahuja V, Midha V, Sinha SK, Pai CG, Kedia S, Mehta V, Bopanna S, Abraham P, Banerjee R, Bhatia S, Chakravartty K, Dadhich S, Desai D, Dwivedi M, Goswami B, Kaur K, Khosla R, Kumar A, Mahajan R, Misra SP, Peddi K, Singh SP, Singh A
- KMID: 2508562
- Intest Res.
- 2020 Oct;18(4):355-378.
- doi: 10.5217/ir.2019.09176
Despite several recent advances in therapy in inflammatory bowel disease (IBD), 5-aminosalicylic acid (5-ASA) therapy has retained its place especially in ulcerative colitis. This consensus on 5-ASA is obtained through... -
- CITED
-
- Close
- SHARE
-
- Close
- Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn’s disease: the Indian experience
-
Sood A, Singh A, Sudhakar R, Midha V, Mahajan R, Mehta V, Gupta YK, Kaur K
- KMID: 2501383
- Intest Res.
- 2020 Apr;18(2):184-191.
- doi: 10.5217/ir.2019.00094
Background/Aims: Exclusive enteral nutrition (EEN) is recommended for induction of remission in pediatric Crohn’s disease (CD). However, it is not currently recommended for inducing remission in adults. This report describes... -
- CITED
-
- Close
- SHARE
-
- Close
- Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study
-
Mahajan R, Singh A, Kedia S, Kaur K, Midha V, Sahu P, Mehta V, Singh D, Bansal N, Dharni K, Kaushal S, Ahuja V, Sood A
- KMID: 2525073
- Intest Res.
- 2022 Jan;20(1):64-71.
- doi: 10.5217/ir.2020.00100
Background/Aims: Infliximab (IFX) has been used to induce and maintain remission in patients with severe steroid-refractory ulcerative colitis (UC). Long-term use of biologics in developing countries is limited by high... -
- CITED
-
- Close
- SHARE
-
- Close
- Outcome of Pedicle Screw Fixation and Monosegmental Fusion in Patients with Fresh Thoracolumbar Fractures
-
Singh R, Rohilla RK, Kamboj K, Magu NK, Kaur K
- KMID: 2270348
- Asian Spine J.
- 2014 Jun;8(3):298-308.
- doi: 10.4184/asj.2014.8.3.298
STUDY DESIGN: Prospective clinical study. PURPOSE: The present prospective study aims to evaluate the clinical, radiological, and functional and quality of life outcomes in patients with fresh thoracolumbar fractures managed by... -
- CITED
-
- Close
- SHARE
-
- Close
- Magnetic Resonance Imaging of Trunk Musculature and Intervertebral Discs in Patients with Spinal Cord Injury with Thoracolumbar Vertebral Fractures: A Prospective Study
-
Singh R, Wadhwani J, Punia G, Rohilla RK, Kaur K
- KMID: 2510560
- Asian Spine J.
- 2020 Dec;14(6):829-846.
- doi: 10.31616/asj.2019.0003
Study Design: This study is a prospective clinical study. Purpose: This study aims to evaluate the characteristics of trunk musculature and intervertebral discs by using magnetic resonance imaging in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of thiopurines in inflammatory bowel disease: an update
-
Singh A, Mahajan R, Kedia S, Dutta AK, Anand A, Bernstein CN, Desai D, Pai CG, Makharia G, Tevethia HV, Mak JW, Kaur K, Peddi K, Ranjan MK, Arkkila P, Kochhar R, Banerjee R, Sinha SK, Ng SC, Hanauer S, Verma S, Dutta U, Midha V, Mehta V, Ahuja V, Sood A
- KMID: 2525069
- Intest Res.
- 2022 Jan;20(1):11-30.
- doi: 10.5217/ir.2020.00155
Inflammatory bowel disease (IBD), once considered a disease of the Western hemisphere, has emerged as a global disease. As the disease prevalence is on a steady rise, management of IBD... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis
-
Sood A, Mahajan R, Juyal G, Midha V, Grewal CS, Mehta V, Singh A, Joshi MC, Narang V, Kaur K, Sidhu H
- KMID: 2438446
- Intest Res.
- 2019 Jan;17(1):78-86.
- doi: 10.5217/ir.2018.00089
BACKGROUND/AIMS: Four high-quality randomized controlled trials have proven the efficacy of fecal microbiota transplantation (FMT) in active ulcerative colitis (UC). We assessed the efficacy of FMT in a real-world setting... -
- CITED
-
- Close
- SHARE
-
- Close
- Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
-
Sood A, Kaur K, Mahajan R, Midha V, Singh A, Sharma S, Puri AS, Goswami B, Desai D, Pai CG, Peddi K, Philip M, Kochhar R, Nijhawan S, Bhatia S, Rao NS
- KMID: 2515479
- Intest Res.
- 2021 Apr;19(2):206-216.
- doi: 10.5217/ir.2019.09169
Background/Aims: The national registry for inflammatory bowel disease (IBD) was designed to study epidemiology and prescribing pattern of treatment of IBD in India. Methods: A multicenter, cross-sectional, prospective registry was... -
- CITED
-
- Close
- SHARE
-
- Close
